Home
Lineage Cell Therapeutics

Lineage Cell Therapeutics Market Share Analysis for June 2026

At Lineage, our mission is to pioneer a new branch of medicine based on transplanting specific cell types to people with serious medical conditions

Health > Biotechnology and Pharmaceuticals

Domainlineagecell.com

Year Founded1990

Employees51 - 200

Annual Revenue$10M - $15M

Lineage Cell Therapeutics

Lineage Cell Therapeutics (including company regionals)

lineagecell.com

See more website traffic and engagement information

Lineage Cell Therapeutics Revenue up to June 2026 is 10M - 15M

revenue generated by Lineage Cell Therapeutics top domains

Lineage Cell Therapeutics top domains revenue over 3 years

Revenue for Lineage Cell Therapeutics top domains

lineagecell.com10M - 15M

See more with Sales Intelligence

Total visits to Lineage Cell Therapeutics's top domains

Understand Lineage Cell Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

lineagecell.com5.3K

See more with Sales Intelligence

Avg. visit duration in Lineage Cell Therapeutics's top domains

Analyze Lineage Cell Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

lineagecell.com00:00:08

See more with Sales Intelligence

Avg. pageviews on Lineage Cell Therapeutics's top domains

See how Lineage Cell Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

lineagecell.com1.86

See more with Sales Intelligence

Lineage Cell Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Lineage Cell Therapeutics

These are the website technologies, by industry, used by Lineage Cell Therapeutics top domains

Audio Video Media (6)

YouTube

Widget (4)

Twemoji

Advertising (2)

Google Adsense

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Lineage Cell Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLineage Cell Therapeutics, Inc. will attend event B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit on Jul 16th '26.CARLSBAD, Calif.-(BUSINESS WIRE)-$LCTX #LineageCellTherapeutics - Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing "off the shelf" allogeneic cell therapies for serious medical conditions, today announced that Brian M. Culley, Lineage's Chief Executive Officer, will be presenting at the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit, in a fireside chat hosted by Mayank Mamtani, Senior Managing Director, Group Head of Healthcare Research and Senior Biotechnology Analyst.

NewsLineage Cell Therapeutics, Inc. launches preclinical COR1 program for corneal endothelial disease.Lineage launches preclinical COR1 program for corneal endothelial disease.

NewsLineage Cell Therapeutics, Inc. partnered with Demant Group on Aug 8th '25.Lineage announced its partnership last month with William Demant Invest A/S, which is wholly owned by the William Demant Foundation, an evergreen investor in hearing health research and the majority shareholder of the Danish hearing health care company Demant A/S.